Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide. (Record no. 3389722)

MARC details
000 -LEADER
fixed length control field 01319 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512051249.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198807s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0031-6970
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/BF00614553
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Back, D J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19880729
245 00 - TITLE STATEMENT
Title Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of clinical pharmacology
Date of publication, distribution, etc. 1988
300 ## - PHYSICAL DESCRIPTION
Extent 157-63 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipyrine
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cimetidine
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Half-Life
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxidation-Reduction
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical Preparations
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Primaquine
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfaphenazole
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tolbutamide
General subdivision pharmacology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tjia, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mönig, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ohnhaus, E E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Park, B K
773 0# - HOST ITEM ENTRY
Title European journal of clinical pharmacology
Related parts vol. 34
-- no. 2
-- p. 157-63
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/BF00614553">https://doi.org/10.1007/BF00614553</a>
Public note Available from publisher's website

No items available.